---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013466"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T02:15:14.622684+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enveric stockholders approve conditional reverse stock split to avoid Nasdaq delisting

## Summary
- Stockholders authorized board to implement reverse stock split between 1:5 and 1:50 if Nasdaq issues bid price delisting determination before Jan 28, 2026.
- Reverse stock split proposal passed with 881,471 votes for, 301,346 against, 23,681 abstentions.
- All six director nominees elected; Michael D. Webb received 175,763 votes for, 155,118 withheld (875,617 broker non-votes).
- Say-on-pay proposal passed with 253,560 votes for, 75,850 against, 1,471 abstentions.
- Auditor ratification of CBIZ CPAs P.C. passed with 1,082,606 votes for, 115,857 against, 8,035 abstentions.

## SEC filing metadata
- accession: 0001641172-25-013466
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000164117225013466/0001641172-25-013466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000164117225013466/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013466
- JSON: https://secwatch.observer/filing/0001641172-25-013466.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013466.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.